InceptionR’s Larimar Therapeutics LRMR Stock Holding History

InceptionR’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-44,006	Closed	-$198K	–	804
2026 Q1	$198K	Buy	+44,006	New	+$176K	0.05%	590

Other funds holding LRMR

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

InceptionR's LRMR Position: Q2 2026 in Review

InceptionR sold out of Larimar Therapeutics (LRMR) in Q2 2026, closing a stake of 44,006 shares — an estimated $198K sold.

InceptionR first reported a position in LRMR in Q1 2026 and held it in 1 quarter. The position peaked at $198K in Q1 2026. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

InceptionR reported no remaining Larimar Therapeutics position as of Q2 2026 after selling out during the quarter.
InceptionR sold 44,006 Larimar Therapeutics shares in Q2 2026, an estimated $198K.
InceptionR first reported a position in Larimar Therapeutics in Q1 2026 and held it in 1 quarter.
InceptionR's Larimar Therapeutics position peaked at $198K in Q1 2026.
163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.